Metabolism of Apolipoprotein B Lipoproteins Defined by the Presence of Apolipoprotein C-II and/or Apolipoprotein C-III

被引：0
作者：
Ooi, Esther M. [1 ]
Furtado, Jeremy D. [1 ]
Sacks, Frank M. [1 ]
机构：
[1] Harvard Univ, Sch Publ Hlth, Boston, MA 02115 USA
来源：
CIRCULATION | 2012年 / 126卷 / 21期
关键词：
Apolipoproteins; Lipoproteins; Metabolism; Systems biology;
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
17840
引用
收藏
页数：1
相关论文
共 50 条
  • [31] Apolipoprotein C-III and its defined lipoprotein subspecies in relation to incident diabetes: the Multi-Ethnic Study of Atherosclerosis
    Sarah A. Aroner
    Jeremy D. Furtado
    Frank M. Sacks
    Michael Y. Tsai
    Kenneth J. Mukamal
    Robyn L. McClelland
    Majken K. Jensen
    Diabetologia, 2019, 62 : 981 - 992
  • [32] Sialylated isoforms of apolipoprotein C-III and plasma lipids in subjects with coronary artery disease
    Olivieri, Oliviero
    Chiariello, Carmela
    Martinelli, Nicola
    Castagna, Annalisa
    Speziali, Giulia
    Girelli, Domenico
    Pizzolo, Francesca
    Bassi, Antonella
    Cecconi, Daniela
    Robotti, Elisa
    Manfredi, Marcello
    Conte, Eleonora
    Marengo, Emilio
    CLINICAL CHEMISTRY AND LABORATORY MEDICINE, 2018, 56 (09) : 1542 - 1550
  • [33] Apolipoprotein C-III and its defined lipoprotein subspecies in relation to incident diabetes: the Multi-Ethnic Study of Atherosclerosis
    Aroner, Sarah A.
    Furtado, Jeremy D.
    Sacks, Frank M.
    Tsai, Michael Y.
    Mukamal, Kenneth J.
    McClelland, Robyn L.
    Jensen, Majken K.
    DIABETOLOGIA, 2019, 62 (06) : 981 - 992
  • [34] Simultaneous Quantification of Apolipoprotein C-III O-Glycoforms by Protein-MRM
    Kim, Hyojin
    Cheon, Dong Huey
    Yang, Won Suk
    Baek, Je-Hyun
    JOURNAL OF PROTEOME RESEARCH, 2023, 22 (01) : 91 - 100
  • [35] Efficacy and safety of olezarsen in lowering apolipoprotein C-III and triglycerides in healthy Japanese Americans
    Karwatowska-Prokopczuk, Ewa
    Lesogor, Anastasia
    Yan, Jing-He
    Hoenlinger, Angelika
    Margolskee, Alison
    Li, Lu
    Tsimikas, Sotirios
    LIPIDS IN HEALTH AND DISEASE, 2024, 23 (01)
  • [36] CLONING AND SEQUENCING OF BOVINE APOLIPOPROTEIN-E COMPLEMENTARY-DNA AND MOLECULAR EVOLUTION OF APOLIPOPROTEIN-E, APOLIPOPROTEIN-C-I, AND APOLIPOPROTEIN-C-II
    YANG, YW
    CHAN, L
    LI, WH
    JOURNAL OF MOLECULAR EVOLUTION, 1991, 32 (06) : 469 - 475
  • [37] Relationship between apolipoprotein C-III concentrations and high-density lipoprotein subclass distribution
    Tian, Li
    Wu, Jin
    Fu, Mingde
    Xu, Yanhua
    Jia, Lianqun
    METABOLISM-CLINICAL AND EXPERIMENTAL, 2009, 58 (05): : 668 - 674
  • [38] Plasma Apolipoprotein C-III Levels, Triglycerides, and Coronary Artery Calcification in Type 2 Diabetics
    Qamar, Arman
    Khetarpal, Sumeet A.
    Khera, Amit V.
    Qasim, Atif
    Rader, Daniel J.
    Reilly, Muredach P.
    ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY, 2015, 35 (08) : 1880 - 1888
  • [39] Disialylated apolipoprotein C-III proteoform is associated with improved lipids in prediabetes and type 2 diabetes
    Koska, Juraj
    Yassine, Hussein
    Trenchevska, Olgica
    Sinari, Shripad
    Schwenke, Dawn C.
    Yen, Frances T.
    Billheimer, Dean
    Nelson, Randall W.
    Nedelkov, Dobrin
    Reaven, Peter D.
    JOURNAL OF LIPID RESEARCH, 2016, 57 (05) : 894 - 905
  • [40] Evaluation of efficacy and safety of antisense inhibition of apolipoprotein C-III with volanesorsen in patients with severe hypertriglyceridemia
    D'Erasmo, Laura
    Gallo, Antonio
    Di Costanzo, Alessia
    Bruckert, Eric
    Arca, Marcello
    EXPERT OPINION ON PHARMACOTHERAPY, 2020, 21 (14) : 1675 - 1684
12345